These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34026572)

  • 21. [A brief scale to assess cognitive impairment in psychiatric patients].
    Pino O; Guilera G; Gómez J; Rojo JE; Vellejo J; Purdon SE
    Psicothema; 2006 Aug; 18(3):447-52. PubMed ID: 17296070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy.
    Pinna F; Fiorillo A; Tusconi M; Guiso B; Carpiniello B
    Int J Ment Health Syst; 2015; 9():37. PubMed ID: 26526168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools.
    Ott CV; Bjertrup AJ; Jensen JH; Ullum H; Sjælland R; Purdon SE; Vieta E; Kessing LV; Miskowiak KW
    J Affect Disord; 2016 Jan; 190():607-615. PubMed ID: 26583350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The screen for cognitive impairment in psychiatry in patients with borderline personality disorder.
    Folesani F; Belvederi Murri M; Biancosino B; Costa S; Zerbinati L; Caruso R; Nanni MG; Toffanin T; Ferrara M; Purdon SE; Grassi L
    Personal Ment Health; 2022 Nov; 16(4):279-289. PubMed ID: 35146968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The validity and reliability of the Spanish version of the Severe Cognitive Impairment Profile (SCIP) for the cognitive assessment of persons with advanced stages of Alzheimer's disease].
    Buiza C; Montorio-Cerrato I; Yanguas J
    Rev Neurol; 2015 Oct; 61(8):349-56. PubMed ID: 26461128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Persian version of the brief assessment of cognition in schizophrenia in patients with schizophrenia and healthy controls.
    Mazhari S; Parvaresh N; Eslami Shahrbabaki M; Sadeghi MM; Nakhaee N; Keefe RS
    Psychiatry Clin Neurosci; 2014 Feb; 68(2):160-6. PubMed ID: 24552637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder.
    Chianetta JM; Lefebvre M; LeBlanc R; Grignon S
    Schizophr Res; 2008 Oct; 105(1-3):86-94. PubMed ID: 18790606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the cognitive assessment interview to screen cognitive impairment in psychosis.
    Sánchez-Torres AM; Elosúa MR; Lorente-Omeñaca R; Moreno-Izco L; Peralta V; Ventura J; Cuesta MJ
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):629-37. PubMed ID: 27272500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent Validity and Reliability of the Brazilian Version of the Functioning Assessment Short Test in Patients with Schizophrenia.
    Zortéa K; da Silva Magalhães PV; Rosa AR; de Lucena DF; Guimarães LR; Petter Francesconi LP; Pedrini M; Cesar Walz J; Severino Gama C; Kapczinski F; Belmonte-de-Abreu PS
    Value Health Reg Issues; 2012 Dec; 1(2):244-247. PubMed ID: 29702907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The estimation of premorbid intelligence levels in French speakers].
    Mackinnon A; Mulligan R
    Encephale; 2005; 31(1 Pt 1):31-43. PubMed ID: 15971638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls.
    Segarra N; Bernardo M; Gutierrez F; Justicia A; Fernadez-Egea E; Allas M; Safont G; Contreras F; Gascon J; Soler-Insa PA; Menchon JM; Junque C; Keefe RS
    Eur Psychiatry; 2011 Mar; 26(2):69-73. PubMed ID: 20435446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
    Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
    Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).
    Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
    J Psychiatr Res; 2016 Sep; 80():87-92. PubMed ID: 27318892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test in schizophrenia.
    Rademeyer M; Joubert P
    S Afr J Psychiatr; 2016; 22(1):890. PubMed ID: 30263162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
    Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
    Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-cultural adaptation and psychometric properties of the MMSE and MoCA questionnaires in Tanzanian Swahili for a traumatic brain injury population.
    Vissoci JRN; de Oliveira LP; Gafaar T; Haglund MM; Mvungi M; Mmbaga BT; Staton CA
    BMC Neurol; 2019 Apr; 19(1):57. PubMed ID: 30961532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder.
    Ott CV; Knorr U; Jespersen A; Obenhausen K; Røen I; Purdon SE; Kessing LV; Miskowiak KW
    J Affect Disord; 2021 Feb; 281():33-40. PubMed ID: 33285390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Validation of the Cognitive Impairment in Psychiatry (SCIP-S) Screen Scale in Patients with Bipolar Disorder I].
    Castaño Ramírez OM; Martínez Ramírez YA; Marulanda Mejía F; Díaz Cabezas R; Valderrama Sánchez LA; Varela Cifuentes V; Aguirre Acevedo DC
    Rev Colomb Psiquiatr; 2015; 44(1):20-7. PubMed ID: 26578215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary findings on the reliability and validity of the Cantonese Birmingham Cognitive Screen in patients with acute ischemic stroke.
    Pan X; Chen H; Bickerton WL; Lau JK; Kong AP; Rotshtein P; Guo A; Hu J; Humphreys GW
    Neuropsychiatr Dis Treat; 2015; 11():2377-90. PubMed ID: 26396522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
    Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.